313.1 A novel risk factor for immediate pancreas graft failure: hypertension in the donor.
Prof. Diego Cantarovich, France
313.2 Solitary Pancreas Transplantation - Significant Improvement over the 2 last Decades
Angelika C. Gruessner, United States
313.3 Long-Term survival and life-time benefit of pancreas transplantation
Angelika C. Gruessner, United States
313.4 The Tissue Common Response Module (tCRM) score predicts treatment response for acute cellular rejection following pancreas transplant
Dr. Audrey Brown, United States
313.6 Establishment of a genetic signature of ischemia reperfusion injury in a porcine pancreas transplantation model
Dr. Samrat Ray, Canada
313.7 Impact of C1q-fixing donor-specific antibodies on pancreas transplant outcomes
Dr. Ana Claudia Vidigal, Brazil
313.8 Mean fluorescence intensity evolution is a more sensitive predictor than simple positivity of posttransplant donor-specific antibodies in pancreas transplantation outcomes
Dr. Ana Claudia Vidigal, Brazil
313.9 Peripheral blood mononuclear cells transcriptomic profile reveals a more prominent role of innate immune cells in pancreas rejection